Enroll Now
You Must LOG IN to Enroll
Publication Date: 10 July 2025
Risk of transfusion transmission of visceral leishmaniasis
Continuing Education Credits: Hours: 0.5
Course Description
In this presentation, Dr. Sarah Tanaka will initially present a review of visceral leishmaniasis infection, including details of the etiological agent and transmission. Later, she will share details about the risk of transfusion transmission of the infection, including some risk mitigation strategies, which she and the research group she belongs to are exploring.
Course Objectives
- Present data on the risk of transfusion transmission of visceral leishmaniasis.
- Expand the discussion on control measures to minimize the risk of transfusion transmission of visceral leishmaniasis.
Run Time: 0.31.45
Course Instructor Bio(s)
Dr Sarah Tanaka, PhD, BSc.
Post-Doc
Universidade Federal do Triângulo Mineiro
Uberaba, Brazil
Dr Tanaka holds a BSc. in Biomedicine from the Universidade Federal do Triângulo Mineiro and a PhD in Health Sciences from the same institution. She was a Postdoctoral Fellow of the Postgraduate Program of Tropical Medicine and Infectious Diseases in the laboratory of Hematology and Hemotherapy at the Universidade Federal do Triângulo Mineiro. She is a collaborating professor of the Research and Translational Hematology course of the Postgraduate Program in Health Sciences. She has experience in flow cytometry and molecular biology techniques, including investigation of SNPs by PCR-RFLP, conventional PCR, real-time PCR and gene expression analysis. She conducts research in transfusion medicine, focusing on the risks of transfusion transmission of infectious diseases, mainly visceral leishmaniasis and genetic susceptibility to complex diseases, including pre-eclampsia and COVID-19, in addition to collaborating with projects in the areas of hematology-oncology and woman health.
